Yue Sun

About me: I have studied tumor immunity for three years, and my main research is on the function improvement of U-CART. I have mastered experimental operation skills and have good literature reading and learning ability. In life, I have a cheerful personality and can adapt to new environments quickly.

Publications：

1. Zhang N, Liu X, Qin J, Sun Y, Xiong H, Lin B, Liu K, Tan B, Zhang C, Huang C, Ren S, Liu M, Du B. LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment. MolTher. 2023 Jul 5:S1525-0016(23)00372-6. doi: 10.1016/j.ymthe.2023.06.015. PMID: 37408308. (IF: 12.91)

2. Liu X, Sun Y, Lin B, Xiong H, Lu X, Tan B, Zhang C, Liu M, Qin J, Zhang N, Du B. Pan-cancer analysis identifies CD155 as a promising target for CAR-T cell therapy. Genome Med. 2025 Jun 2;17(1):64. doi: 10.1186/s13073-025-01490-0. PMID: 40457441; PMCID: PMC12128359. (IF: 10.4) co-first

3. Cui X, Xing R, Tian Y, Wang M, Sun Y, Xu Y, Yang Y, Zhao Y, Xie L, Xiao Y, Li D, Zheng B, Liu M, Chen H. The G2A Receptor Deficiency Aggravates Atherosclerosis in Rats by Regulating Macrophages and Lipid Metabolism. Front Physiol. 2021 Jul 26;12:659211. doi: 10.3389/fphys.2021.659211. PMID: 34381373; PMCID: PMC8351205. (IF: 3.287)

Patents：

4. Liu Xiaohong, Sun Yue, Du Bing, Tan Binghe, Zhang Na, Liu Mingyao, chimeric antigen receptor targeting immune cell activation receptor. PCT international patent (International application number: PCT/CN2023/135665)